The first to launch was the ACTT-1 trial, though it didn't have that name when it began at the University of Nebraska Medical ...

A September 2024 article in the journal Biomedicines reviewing the findings of clinical trials for ivermectin and chloroquine ...

The World Health Organization halted the hydroxychloroquine arm of its SOLIDARITY trial at the beginning of the month, in patients who are already hospitalised. This followed a pause a month after ...

The World Health Organization has restarted its trial of COVID-19 drug hydroxychloroquine, the malaria drug favoured by president Donald Trump, after a temporary halt because of safety concerns.

This story is a sidebar to a main story about findings from the earliest clinical trials launched during the COVID pandemic.

with the World Health Organization halting its trials at the end of May. So, what exactly is hydroxychloroquine? And will it help with the fight against COVID-19? This is hydroxychloroquine ...

Update (June 18): The World Health Organization announced yesterday that it was dropping hydroxychloroquine from the Solidarity trial after new data suggest the drug is ineffective as a COVID-19 ...

reported harmful effects tied to the anti-malaria drug hydroxychloroquine among patients with COVID-19. In response to the findings, the World Health Organization (WHO) and several other health ...

In fact, some early clinical trials on people with Covid who took hydroxychloroquine also found that those patients had a higher risk of dying from the virus compared to those who didn’t take ...

Scientists are doing clinical trials to try to find out more about using hydroxychloroquine to treat the coronavirus. However, randomized clinical trials take a long time and may not be feasible ...

A cohort study finds that hydroxychloroquine use in cutaneous lupus erythematosus reduces the risk of developing systemic ...